Target identification and mechanism of action in chemical biology and drug discovery.

Target-identification and mechanism-of-action studies have important roles in small-molecule probe and drug discovery. Biological and technological advances have resulted in the increasing use of cell-based assays to discover new biologically active small molecules. Such studies allow small-molecule action to be tested in a more disease-relevant setting at the outset, but they require follow-up studies to determine the precise protein target or targets responsible for the observed phenotype. Target identification can be approached by direct biochemical methods, genetic interactions or computational inference. In many cases, however, combinations of approaches may be required to fully characterize on-target and off-target effects and to understand mechanisms of small-molecule action.

[1]  C. Anfinsen,et al.  Selective enzyme purification by affinity chromatography. , 1968, Proceedings of the National Academy of Sciences of the United States of America.

[2]  M. Yoshida,et al.  Effects of trichostatins on differentiation of murine erythroleukemia cells. , 1987, Cancer research.

[3]  D A Scudiero,et al.  Display and analysis of patterns of differential activity of drugs against human tumor cell lines: development of mean graph and COMPARE algorithm. , 1989, Journal of the National Cancer Institute.

[4]  S. Schreiber,et al.  A receptor for the immuno-suppressant FK506 is a cis–trans peptidyl-prolyl isomerase , 1989, Nature.

[5]  S. Schreiber,et al.  The mechanism of action of cyclosporin A and FK506. , 1992, Immunology today.

[6]  Jun O. Liu,et al.  Inhibition of T cell signaling by immunophilin-ligand complexes correlates with loss of calcineurin phosphatase activity. , 1992, Biochemistry.

[7]  Stuart L. Schreiber,et al.  A mammalian protein targeted by G1-arresting rapamycin–receptor complex , 1994, Nature.

[8]  T. Mitchison,et al.  Towards a pharmacological genetics. , 1994, Chemistry & biology.

[9]  David M. Rocke,et al.  Predicting ligand binding to proteins by affinity fingerprinting. , 1995, Chemistry & biology.

[10]  S. Schreiber,et al.  A Mammalian Histone Deacetylase Related to the Yeast Transcriptional Regulator Rpd3p , 1996, Science.

[11]  G. S. Johnson,et al.  An Information-Intensive Approach to the Molecular Pharmacology of Cancer , 1997, Science.

[12]  A. Fire,et al.  Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans , 1998, Nature.

[13]  S. Schreiber Chemical genetics resulting from a passion for synthetic organic chemistry. , 1998, Bioorganic & medicinal chemistry.

[14]  Steven L. Dixon,et al.  Bioactive Diversity and Screening Library Selection via Affinity Fingerprinting , 1998, J. Chem. Inf. Comput. Sci..

[15]  P. Brown,et al.  Drug target validation and identification of secondary drug target effects using DNA microarrays , 1998, Nature Medicine.

[16]  L Meijer,et al.  Discovery and initial characterization of the paullones, a novel class of small-molecule inhibitors of cyclin-dependent kinases. , 1999, Cancer research.

[17]  S. Gygi,et al.  Quantitative analysis of complex protein mixtures using isotope-coded affinity tags , 1999, Nature Biotechnology.

[18]  Yudong D. He,et al.  Functional Discovery via a Compendium of Expression Profiles , 2000, Cell.

[19]  B. Stockwell Chemical genetics: ligand-based discovery of gene function , 2000, Nature Reviews Genetics.

[20]  S A Sundberg,et al.  High-throughput and ultra-high-throughput screening: solution- and cell-based approaches. , 2000, Current opinion in biotechnology.

[21]  M. Mann,et al.  Stable Isotope Labeling by Amino Acids in Cell Culture, SILAC, as a Simple and Accurate Approach to Expression Proteomics* , 2002, Molecular & Cellular Proteomics.

[22]  Ruedi Aebersold,et al.  The study of macromolecular complexes by quantitative proteomics , 2003, Nature Genetics.

[23]  Blagoy Blagoev,et al.  A proteomics strategy to elucidate functional protein-protein interactions applied to EGF signaling , 2003, Nature Biotechnology.

[24]  Shu-Hui Chen,et al.  Stable-isotope dimethyl labeling for quantitative proteomics. , 2003, Analytical chemistry.

[25]  Andrew H. Thompson,et al.  Tandem mass tags: a novel quantification strategy for comparative analysis of complex protein mixtures by MS/MS. , 2003, Analytical chemistry.

[26]  R. Aebersold,et al.  Mass spectrometry-based proteomics , 2003, Nature.

[27]  Tae-Wook Kang,et al.  Facilitated forward chemical genetics using a tagged triazine library and zebrafish embryo screening. , 2003, Journal of the American Chemical Society.

[28]  Yoshiya Oda,et al.  Quantitative chemical proteomics for identifying candidate drug targets. , 2003, Analytical chemistry.

[29]  Norbert Perrimon,et al.  Parallel Chemical Genetic and Genome-Wide RNAi Screens Identify Cytokinesis Inhibitors and Targets , 2004, PLoS biology.

[30]  L. Burdine,et al.  Target identification in chemical genetics: the (often) missing link. , 2004, Chemistry & biology.

[31]  Grant W. Brown,et al.  Integration of chemical-genetic and genetic interaction data links bioactive compounds to cellular target pathways , 2004, Nature Biotechnology.

[32]  D. Brehmer,et al.  Proteome-wide Identification of Cellular Targets Affected by Bisindolylmaleimide-type Protein Kinase C Inhibitors* , 2004, Molecular & Cellular Proteomics.

[33]  M. Cotten,et al.  Chemical Proteomic Analysis Reveals Alternative Modes of Action for Pyrido[2,3-d]pyrimidine Kinase Inhibitors* , 2004, Molecular & Cellular Proteomics.

[34]  T. Terada,et al.  Design and synthesis of novel hydrophilic spacers for the reduction of nonspecific binding proteins on affinity resins. , 2004, Bioorganic & medicinal chemistry.

[35]  K. Parker,et al.  Multiplexed Protein Quantitation in Saccharomyces cerevisiae Using Amine-reactive Isobaric Tagging Reagents*S , 2004, Molecular & Cellular Proteomics.

[36]  B. Stockwell Exploring biology with small organic molecules , 2004, Nature.

[37]  Xiaofeng S Zheng,et al.  Genetic and genomic approaches to identify and study the targets of bioactive small molecules. , 2004, Chemistry & biology.

[38]  Lani F. Wu,et al.  Multidimensional Drug Profiling By Automated Microscopy , 2004, Science.

[39]  Todd R Golub,et al.  Gene expression–based high-throughput screening(GE-HTS) and application to leukemia differentiation , 2004, Nature Genetics.

[40]  Paul A Clemons,et al.  Complex phenotypic assays in high-throughput screening. , 2004, Current opinion in chemical biology.

[41]  Paul A Clemons,et al.  Relationship of stereochemical and skeletal diversity of small molecules to cellular measurement space. , 2004, Journal of the American Chemical Society.

[42]  A. Heck,et al.  Development of a Novel Chemical Probe for the Selective Enrichment of Phosphorylated Serine‐ and Threonine‐Containing Peptides , 2005, Chembiochem : a European journal of chemical biology.

[43]  D. Bojanic,et al.  Keynote review: in vitro safety pharmacology profiling: an essential tool for successful drug development. , 2005, Drug discovery today.

[44]  M. Mann,et al.  Mass spectrometry–based proteomics turns quantitative , 2005, Nature chemical biology.

[45]  B. Cravatt,et al.  A tandem orthogonal proteolysis strategy for high-content chemical proteomics. , 2005, Journal of the American Chemical Society.

[46]  M. Fielden,et al.  Development of a large-scale chemogenomics database to improve drug candidate selection and to understand mechanisms of chemical toxicity and action. , 2005, Journal of biotechnology.

[47]  L. Wodicka,et al.  A small molecule–kinase interaction map for clinical kinase inhibitors , 2005, Nature Biotechnology.

[48]  K. Anderson,et al.  Analysis of mouse embryonic patterning and morphogenesis by forward genetics , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[49]  A. Saghatelian,et al.  Target discovery in small-molecule cell-based screens by in situ proteome reactivity profiling , 2005, Nature Biotechnology.

[50]  Lin Tang,et al.  Roscovitine Targets, Protein Kinases and Pyridoxal Kinase*[boxs] , 2005, Journal of Biological Chemistry.

[51]  J. N. Kay,et al.  Forward Genetic Analysis of Visual Behavior in Zebrafish , 2005, PLoS genetics.

[52]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[53]  A. Fliri,et al.  Biological spectra analysis: Linking biological activity profiles to molecular structure. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[54]  Eric J Kunkel,et al.  Characterization of compound mechanisms and secondary activities by BioMAP analysis. , 2006, Journal of pharmacological and toxicological methods.

[55]  Meir Glick,et al.  Prediction of Biological Targets for Compounds Using Multiple-Category Bayesian Models Trained on Chemogenomics Databases , 2006, J. Chem. Inf. Model..

[56]  Paul A Clemons,et al.  The Connectivity Map: Using Gene-Expression Signatures to Connect Small Molecules, Genes, and Disease , 2006, Science.

[57]  Eric W. Klee,et al.  Genome-Wide Reverse Genetics Framework to Identify Novel Functions of the Vertebrate Secretome , 2006, PloS one.

[58]  G. V. Paolini,et al.  Global mapping of pharmacological space , 2006, Nature Biotechnology.

[59]  Anne E Carpenter,et al.  A Lentiviral RNAi Library for Human and Mouse Genes Applied to an Arrayed Viral High-Content Screen , 2006, Cell.

[60]  D. Guertin,et al.  Functional Genomics Identifies TOR-Regulated Genes that Control Growth and Division , 2006, Current Biology.

[61]  T. Golub,et al.  Gene expression signature-based chemical genomic prediction identifies a novel class of HSP90 pathway modulators. , 2006, Cancer cell.

[62]  Corey Nislow,et al.  A unique and universal molecular barcode array , 2006, Nature Methods.

[63]  H. Schöler,et al.  Self-renewal of embryonic stem cells by a small molecule , 2006, Proceedings of the National Academy of Sciences.

[64]  S. Haggarty,et al.  Revealing complex traits with small molecules and naturally recombinant yeast strains. , 2006, Chemistry & biology.

[65]  M. Bogyo,et al.  A mild chemically cleavable linker system for functional proteomic applications. , 2007, Angewandte Chemie.

[66]  Christopher P Austin,et al.  High-throughput screening assays for the identification of chemical probes. , 2007, Nature chemical biology.

[67]  G. Terstappen,et al.  Target deconvolution strategies in drug discovery , 2007, Nature Reviews Drug Discovery.

[68]  Minoru Yoshida,et al.  [Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by trichostatin A]. , 1990, Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme.

[69]  Stuart L Schreiber,et al.  Genetic basis of individual differences in the response to small-molecule drugs in yeast , 2007, Nature Genetics.

[70]  A. Tanaka [A receptor for the immunosuppressant FK506 is a cis-trans peptidyl-prolyl isomerase]. , 2007, Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme.

[71]  Dennis B. Troup,et al.  NCBI GEO: mining tens of millions of expression profiles—database and tools update , 2006, Nucleic Acids Res..

[72]  Anne E Carpenter Image-based chemical screening. , 2007, Nature chemical biology.

[73]  Bernhard Kuster,et al.  Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors , 2007, Nature Biotechnology.

[74]  Young-Tae Chang,et al.  Tagged library approach facilitates forward chemical genetics. , 2007, Molecular bioSystems.

[75]  M. Bogyo,et al.  Proteomics Evaluation of Chemically Cleavable Activity-based Probes* , 2007, Molecular & Cellular Proteomics.

[76]  Xiaodong Wang,et al.  Diazonamide toxins reveal an unexpected function for ornithine δ-amino transferase in mitotic cell division , 2007, Proceedings of the National Academy of Sciences.

[77]  K. Shokat,et al.  Chemical Genetics: Where Genetics and Pharmacology Meet , 2007, Cell.

[78]  Heng Zhu,et al.  Applications of protein microarray technology. , 2007, Combinatorial chemistry & high throughput screening.

[79]  Michael J. Keiser,et al.  Relating protein pharmacology by ligand chemistry , 2007, Nature Biotechnology.

[80]  Martin Serrano,et al.  Nucleic Acids Research Advance Access published October 18, 2007 ChemBank: a small-molecule screening and , 2007 .

[81]  Stephen T. C. Wong,et al.  Cellular Phenotype Recognition for High-Content RNA Interference Genome-Wide Screening , 2008, Journal of biomolecular screening.

[82]  Peter G. Schultz,et al.  In silico activity profiling reveals the mechanism of action of antimalarials discovered in a high-throughput screen , 2008, Proceedings of the National Academy of Sciences.

[83]  Frank E Koehn,et al.  High impact technologies for natural products screening. , 2008, Progress in drug research. Fortschritte der Arzneimittelforschung. Progres des recherches pharmaceutiques.

[84]  B. Doble,et al.  Prevention of Amino Acid Conversion in SILAC Experiments with Embryonic Stem Cells * , 2008, Molecular & Cellular Proteomics.

[85]  Michael Boutros,et al.  The art and design of genetic screens: RNA interference , 2008, Nature Reviews Genetics.

[86]  A. Hopkins Network pharmacology: the next paradigm in drug discovery. , 2008, Nature chemical biology.

[87]  John A. Tallarico,et al.  Integrating high-content screening and ligand-target prediction to identify mechanism of action. , 2008, Nature chemical biology.

[88]  M. Mann,et al.  Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle. , 2008, Molecular cell.

[89]  Stuart L. Schreiber,et al.  Towards the Optimal Screening Collection: A Synthesis Strategy. , 2008 .

[90]  Makoto Muroi,et al.  The identification of an osteoclastogenesis inhibitor through the inhibition of glyoxalase I , 2008, Proceedings of the National Academy of Sciences.

[91]  K. Shokat,et al.  Targeted polypharmacology: Discovery of dual inhibitors of tyrosine and phosphoinositide kinases , 2008, Nature chemical biology.

[92]  Yoshihiro Yamanishi,et al.  Prediction of drug–target interaction networks from the integration of chemical and genomic spaces , 2008, ISMB.

[93]  P. Bork,et al.  Drug Target Identification Using Side-Effect Similarity , 2008, Science.

[94]  R. Sinden,et al.  Reverse genetics screen identifies six proteins important for malaria development in the mosquito , 2008, Molecular microbiology.

[95]  Paul A Clemons,et al.  Connecting synthetic chemistry decisions to cell and genome biology using small-molecule phenotypic profiling. , 2009, Current opinion in chemical biology.

[96]  Yanli Wang,et al.  PubChem: a public information system for analyzing bioactivities of small molecules , 2009, Nucleic Acids Res..

[97]  Wen-Lian Hsu,et al.  MaXIC-Q Web: a fully automated web service using statistical and computational methods for protein quantitation based on stable isotope labeling and LC–MS , 2009, Nucleic Acids Res..

[98]  John A. Tallarico,et al.  Multi-parameter phenotypic profiling: using cellular effects to characterize small-molecule compounds , 2009, Nature Reviews Drug Discovery.

[99]  G. Superti-Furga,et al.  Target profiling of small molecules by chemical proteomics. , 2009, Nature chemical biology.

[100]  Reinout Raijmakers,et al.  Multiplex peptide stable isotope dimethyl labeling for quantitative proteomics , 2009, Nature Protocols.

[101]  R. Higgs,et al.  Capture of drug targets from live cells using a multipurpose immuno-chemo-proteomics tool. , 2009, Journal of proteome research.

[102]  Bin Chen,et al.  PubChem as a Source of Polypharmacology , 2009, J. Chem. Inf. Model..

[103]  T. Golub,et al.  Empirical Bayes Analysis of Quantitative Proteomics Experiments , 2009, PloS one.

[104]  Steven A Carr,et al.  Identifying the proteins to which small-molecule probes and drugs bind in cells , 2009, Proceedings of the National Academy of Sciences.

[105]  Lorenz M Mayr,et al.  Novel trends in high-throughput screening. , 2009, Current opinion in pharmacology.

[106]  Michael J. Keiser,et al.  Predicting new molecular targets for known drugs , 2009, Nature.

[107]  Paul A. Clemons,et al.  Using biological performance similarity to inform disaccharide library design. , 2009, Journal of the American Chemical Society.

[108]  K. Shokat,et al.  Targeting the cancer kinome through polypharmacology , 2010, Nature Reviews Cancer.

[109]  Toshihiko Ogura,et al.  Identification of a Primary Target of Thalidomide Teratogenicity , 2010, Science.

[110]  R. Tagliaferri,et al.  Discovery of drug mode of action and drug repositioning from transcriptional responses , 2010, Proceedings of the National Academy of Sciences.

[111]  Joshua A. Bittker,et al.  Small-molecule inducers of insulin expression in pancreatic α-cells , 2010, Proceedings of the National Academy of Sciences.

[112]  Ravi Iyengar,et al.  Systems pharmacology. , 2010, The Mount Sinai journal of medicine, New York.

[113]  K. Chou,et al.  Predicting Drug-Target Interaction Networks Based on Functional Groups and Biological Features , 2010, PloS one.

[114]  Brett R. Murphy,et al.  Chemical proteomics identifies Nampt as the target of CB30865, an orphan cytotoxic compound. , 2010, Chemistry & biology.

[115]  Anne E Carpenter,et al.  Small molecules discovered in a pathway screen target the Rho pathway in cytokinesis , 2010, Nature chemical biology.

[116]  M. Mann,et al.  MSQuant, an open source platform for mass spectrometry-based quantitative proteomics. , 2010, Journal of proteome research.

[117]  T. Muchamuel,et al.  Nonproteasomal Targets of the Proteasome Inhibitors Bortezomib and Carfilzomib: a Link to Clinical Adverse Events , 2011, Clinical Cancer Research.

[118]  D. Bojanic,et al.  Impact of high-throughput screening in biomedical research , 2011, Nature Reviews Drug Discovery.

[119]  Dana Pe'er,et al.  Modulatory profiling identifies mechanisms of small molecule-induced cell death , 2011, Proceedings of the National Academy of Sciences.

[120]  Lei Xie,et al.  Structure-based systems biology for analyzing off-target binding. , 2011, Current opinion in structural biology.

[121]  Jeremy R. Duvall,et al.  AAK1 identified as an inhibitor of neuregulin-1/ErbB4-dependent neurotrophic factor signaling using integrative chemical genomics and proteomics. , 2011, Chemistry & biology.

[122]  Andreas Bender,et al.  From in silico target prediction to multi-target drug design: current databases, methods and applications. , 2011, Journal of proteomics.

[123]  R. Olsen,et al.  Identification of Direct Protein Targets of Small Molecules , 2010, ACS chemical biology.

[124]  Ian H Gilbert,et al.  Target Validation: Linking Target and Chemical Properties to Desired Product Profile , 2011, Current topics in medicinal chemistry.

[125]  Bryan L. Roth,et al.  Chemical Informatics and Target Identification in a Zebrafish Phenotypic Screen , 2011, Nature chemical biology.

[126]  E. Winzeler,et al.  Target identification and validation of novel antimalarials. , 2011, Future microbiology.

[127]  M. Mann,et al.  Andromeda: a peptide search engine integrated into the MaxQuant environment. , 2011, Journal of proteome research.

[128]  Michael Schroeder,et al.  Old friends in new guise: repositioning of known drugs with structural bioinformatics , 2011, Briefings Bioinform..

[129]  D. Swinney,et al.  How were new medicines discovered? , 2011, Nature Reviews Drug Discovery.

[130]  D R Mani,et al.  iTRAQ Labeling is Superior to mTRAQ for Quantitative Global Proteomics and Phosphoproteomics* , 2011, Molecular & Cellular Proteomics.

[131]  Yanli Wang,et al.  Identifying Compound-Target Associations by Combining Bioactivity Profile Similarity Search and Public Databases Mining , 2011, J. Chem. Inf. Model..

[132]  Peter S. Kutchukian,et al.  Rethinking molecular similarity: comparing compounds on the basis of biological activity. , 2012, ACS chemical biology.

[133]  Anne E Carpenter,et al.  Identification of Regulators of Polyploidization Presents Therapeutic Targets for Treatment of AMKL , 2012, Cell.

[134]  Forest M White,et al.  Systems-pharmacology dissection of a drug synergy in imatinib-resistant CML. , 2012, Nature chemical biology.

[135]  Olivier Elemento,et al.  Using transcriptome sequencing to identify mechanisms of drug action and resistance , 2011, Nature chemical biology.

[136]  B. Cravatt,et al.  Fully functionalized small-molecule probes for integrated phenotypic screening and target identification. , 2012, Journal of the American Chemical Society.

[137]  Peter C. St. John,et al.  Identification of Small Molecule Activators of Cryptochrome , 2012, Science.

[138]  Jongmin Park,et al.  Discovery and target identification of an antiproliferative agent in live cells using fluorescence difference in two-dimensional gel electrophoresis. , 2012, Angewandte Chemie.

[139]  David R Spring,et al.  Diversity-oriented synthesis: producing chemical tools for dissecting biology. , 2012, Chemical Society reviews.

[140]  A. Dopazo,et al.  Identification of disease-relevant genes for molecularly-targeted drug discovery. , 2012, Current cancer drug targets.

[141]  A. Emili,et al.  Target Identification by Chromatographic Co-elution: Monitoring of Drug-Protein Interactions without Immobilization or Chemical Derivatization* , 2012, Molecular & Cellular Proteomics.

[142]  David R. Spring,et al.  Diversity-Oriented Synthesis: Producing Chemical Tools for Dissecting Biology , 2012 .

[143]  Selective killing of cancer cells by a small molecule targeting the stress response to ROS , 2012, Nature.

[144]  J. Irwin,et al.  Identifying mechanism-of-action targets for drugs and probes , 2012, Proceedings of the National Academy of Sciences.

[145]  Michael J. Keiser,et al.  Large Scale Prediction and Testing of Drug Activity on Side-Effect Targets , 2012, Nature.

[146]  Stefan Wetzel,et al.  Charting, navigating, and populating natural product chemical space for drug discovery. , 2012, Journal of medicinal chemistry.

[147]  Chee Keong Kwoh,et al.  Drug-target interaction prediction by learning from local information and neighbors , 2013, Bioinform..

[148]  Charles Boone,et al.  Systems-level antimicrobial drug and drug synergy discovery. , 2013, Nature chemical biology.